
    
      This first in human study is designed to investigate the tolerability, safety,
      pharmacokinetics and preliminarily pharmacodynamics following topical administration of
      single and multiple ascending doses of CHF6467 in subjects diagnosed with diabetic foot ulcer
      (DFU).
    
  